Projecten

Global analysis of DNA and phosphoproteins will identify predictive biomarker for new esophageal cancer treatment

Extracellular liver matrix and liver organoids will be joint ex-vivo to generate essential liver function

Q-Maestro: Quantification of brain reperfusion in X-ray images in endovascular treatment of stroke patients

To more accurately characterise low-grade prostatic cancer with MR imaging, to improve patient outcome

HeartCHIP II will develop an automated optical analysis system for organ-on-chip cardiomyocyte contraction analysis

Organoids are superior novel tool to predict absorption, metabolism and toxicity in drug development

Better diagnosis, prognostics and treatment of retinal diseases by non-invasive measurements of retinal flow

Obruza does most of the work for regenerative medicine researchers through integrated automation

This study will define kidney donors which can be safely used for transplantation without risk of rejection

In this study the consortium will perform an external biomarker validation on fecal immunochemical test samples